OTC:NEVPF

Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)

LUND, Sweden, May 31, 2018 /PRNewswire/ --NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF),the mitochondrial medicine company, today announced an increase of the number of shares and votes in NeuroVive of 39,244,644 as a result of a preferential rights issue in NeuroVive Pharma...

2018-05-31 20:09 2072

NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development

LUND, Sweden and SEOUL, South Korea, May 21, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today jointly announced positive topline results after data base lock in the phase I single...

2018-05-21 17:26 1731

Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)

LUND, Sweden, Feb. 15, 2018 /PRNewswire/ -- The shareholders of NeuroVive Pharmaceutical AB (publ), 556595-6538, are hereby convened to the Extraordinary General Meeting, held at2 pm on Thursday 22 March 2018 at Medicon Village, Scheelevagen 2, in Lund, Sweden. Entitlement to participate and no...

2018-02-15 16:35 1568

NeuroVive Board Chair Resigns, New Chair Elected

LUND, Sweden, Nov. 7, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces thatGregory Batcheller resigned as Chair of the NeuroVive Pharmaceutical AB Board effective midnightNovember 6, 2017. He had served as the Executive Chair of NeuroVive for the p...

2017-11-07 15:55 1436

NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million

LUND, Sweden, Nov. 3, 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), a leading company in mitochondrial medicine, announced today that the company is conducting a directed new issue of shares, which is expected to add close toSEK 5.3 million to NeuroVive...

2017-11-03 16:33 1490

Week's Top Stories